Irbesartan (Westminster Pharmaceuticals, LLC)
Welcome to the PulseAid listing for the Irbesartan drug offered from Westminster Pharmaceuticals, LLC. This Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Westminster Pharmaceuticals, LLC |
NON-PROPRIETARY NAME: | Irbesartan |
SUBSTANCE NAME: | IRBESARTAN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-02-01 |
END MARKETING DATE: | 0000-00-00 |
Irbesartan HUMAN PRESCRIPTION DRUG Details:
Item Description | Irbesartan from Westminster Pharmaceuticals, LLC |
LABELER NAME: | Westminster Pharmaceuticals, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 75(mg/75mg) |
START MARKETING DATE: | 2016-02-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69367-119_2aba2a7a-306f-3711-e054-00144ff88e88 |
PRODUCT NDC: | 69367-119 |
APPLICATION NUMBER: | ANDA204774 |
Other IRBESARTAN Pharmaceutical Manufacturers / Labelers: